Skip to content
← Full study record

NCT00787761 · MORE INFO

Limitations, agreements, and source contact

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer · Source last updated 2012-10-01

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
abashey@bmtga.com
organization
Blood and Marrow Transplant Group of Georgia
phone
404-255-1930
title
Asad Bashey, MD, PhD, Principal Investigator
Complete source fields
certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
abashey@bmtga.com
organization
Blood and Marrow Transplant Group of Georgia
phone
404-255-1930
title
Asad Bashey, MD, PhD, Principal Investigator

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice